Evidence map›Paper›PMID 33921372›Full record

ArticleInternational journal of molecular sciences2021

Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy.

Hye Ran Kim, Jin Cheol Kim, Seok Young Kang, Hye One Kim, Chun Wook Park, Bo Young Chung

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Melittin attenuates imiquimod-induced psoriatic dermatitis in mice: a role for autophagy activation via PI3K/Akt/mTOR pathway suppression.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Dialogue between programmed cell death and psoriasis.Postepy dermatologii i alergologii · 2025
    Review
  8. Trifolirhizin improves the hyperproliferation and excessive inflammatory response in human HaCaT keratinocytes and ameliorates skin lesions in psoriasis-like mouse models.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  9. Article
  10. Rapamycin Attenuates HTissue engineering and regenerative medicine · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hye Ran KimDepartment of Dermatology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07441, Korea.ORCID 0000-0001-7519-8910
Jin Cheol KimDepartment of Dermatology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07441, Korea.ORCID 0000-0002-1523-6951
Seok Young KangDepartment of Dermatology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07441, Korea.ORCID 0000-0001-6532-2244
Hye One KimDepartment of Dermatology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07441, Korea.ORCID 0000-0001-5846-0008
Chun Wook ParkDepartment of Dermatology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07441, Korea.
Bo Young ChungDepartment of Dermatology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07441, Korea.ORCID 0000-0002-2795-0140
Hallym University · KR

Funding

Hallym University HURF-2019-72Ministry of Science and ICT, South Korea 2018R1C1B6007998
6 · The paper itself

Abstract

Recently, the mTOR signaling has emerged as an important player in the pathogenesis of psoriasis. We previously found that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced psoriatic skin inflammation was related to the inhibition of autophagy in keratinocytes. However, the effects and detailed molecular mechanisms of the mTOR inhibitor rapamycin and TCDD on psoriasis in vivo remain to be elucidated. In this study, we aimed to evaluate the effects of rapamycin and TCDD on skin lesions in imiquimod (IMQ)-induced psoriasis using a mouse model. TCDD aggravated skin inflammation in an IMQ-induced psoriatic mouse model. Furthermore, TCDD increased the expression of aryl hydrocarbon receptor (AHR), CYP1A1, proinflammatory cytokines, oxidative stress markers (NADPH oxidase (Nox) 2, Nox4), and phosphorylated P65NF-ĸB, whereas the expression of autophagy-related factors and the antioxidant marker nuclear factor-erythroid 2-related factor 2 (NRF2) decreased. Rapamycin reduced the aggravated skin inflammation induced by TCDD and restored TCDD-induced autophagy suppression and the increase of AHR expression, oxidative stress, and inflammatory response in the skin lesions of a psoriatic mouse model. In conclusion, we demonstrated that rapamycin alleviates TCDD-induced aggravated dermatitis in mice with imiquimod-induced psoriasis-like dermatitis through AHR and autophagy modulation.

Indexed as

AnimalsAutophagyCell DifferentiationCells, CulturedCytochrome P-450 CYP1A1DermatitisGene Expression RegulationHumansImiquimodInflammationKeratinocytesMiceNADPH Oxidase 4NF-E2-Related Factor 2Polychlorinated DibenzodioxinsPsoriasisCytochrome P-450 CYP1A1ImiquimodNADPH Oxidase 4Nfe2l2 protein, mouseNF-E2-Related Factor 2Polychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonSirolimus2,3,7,8-tetrachlorodibenzo-p-dioxinaryl hydrocarbon receptorautophagypsoriasisrapamycin

Identifiers

PMID33921372
PMCPMC8069848
OpenAlexW3153998827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.